Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,858 | 192,037 | 157,132 | 183,581 | 97,376 |
| Marketable Securities | 177,244 | 115,745 | 111,208 | 60,046 | 126,404 |
| Receivables | 51,742 | 31,910 | 40,065 | 41,724 | 24,888 |
| Inventories | 41,396 | 48,181 | 22,069 | 26,364 | 28,680 |
| TOTAL | $475,530 | $420,311 | $355,907 | $331,799 | $311,301 |
| Non-Current Assets | |||||
| PPE Net | 1,655 | 1,076 | 606 | 662 | 561 |
| Intangibles | 15,500 | 15,750 | 16,000 | 16,250 | 16,500 |
| Other Non-Current Assets | 219,648 | 224,013 | 226,813 | 231,842 | 226,936 |
| TOTAL | $236,803 | $240,839 | $243,419 | $248,754 | $243,997 |
| Total Assets | $712,333 | $661,150 | $599,326 | $580,553 | $555,298 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,150 | 8,956 | 1,982 | 2,039 | 8,328 |
| Accrued Expenses | 94,223 | 88,348 | 75,901 | 80,512 | 69,527 |
| Other current liabilities | 20,523 | 18,001 | 17,092 | 16,077 | 16,069 |
| TOTAL | $123,592 | $117,827 | $97,267 | $100,621 | $95,955 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,547 | 16,505 | 12,759 | 9,685 | 10,526 |
| TOTAL | $53,358 | $48,316 | $44,570 | $41,496 | $22,337 |
| Total Liabilities | $176,950 | $166,143 | $141,837 | $142,117 | $118,292 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,796 | 74,108 | 72,971 | 72,644 | 72,202 |
| Common Shares | 21 | 21 | 20 | 20 | 20 |
| Retained earnings | -476,337 | -494,772 | -512,604 | -521,143 | -512,255 |
| Other shareholders' equity | -155 | -53 | -165 | -163 | -41 |
| TOTAL | $535,383 | $495,007 | $457,489 | $438,436 | $437,006 |
| Total Liabilities And Equity | $712,333 | $661,150 | $599,326 | $580,553 | $555,298 |